{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:13:13Z","timestamp":1774318393642,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejphar.2021.174081","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T23:43:45Z","timestamp":1619221425000},"page":"174081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats"],"prefix":"10.1016","volume":"902","author":[{"given":"Yan","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Lian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Ke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174081_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","article-title":"SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob(-\/-) mice","volume":"18","author":"Adingupu","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2021.174081_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","article-title":"Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2021.174081_bib3","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/ehf2.13054","article-title":"Endothelial dysfunction and the risk of heart failure in a community-based study: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"\u00c4rnl\u00f6v","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ejphar.2021.174081_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI60329","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2021.174081_bib5","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.freeradbiomed.2007.12.033","article-title":"Regulation of mitochondrial uncoupling respiration during exercise in rat heart: role of reactive oxygen species (ROS) and uncoupling protein 2","volume":"44","author":"Bo","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2021.174081_bib6","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db09-0259","article-title":"Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice","volume":"58","author":"Bugger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174081_bib7","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2337\/diabetes.48.7.1482","article-title":"Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets","volume":"48","author":"Chan","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174081_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000327960","article-title":"Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats","volume":"27","author":"Chen","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174081_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13105-018-0648-7","article-title":"Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats","volume":"75","author":"Diao","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174081_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/dmrr.2343","article-title":"Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy","volume":"29","author":"Donga","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejphar.2021.174081_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/ATVBAHA.107.147595","article-title":"Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure","volume":"27","author":"D\u00fcckelmann","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2021.174081_bib12","doi-asserted-by":"crossref","first-page":"8470394","DOI":"10.1155\/2016\/8470394","article-title":"Assessment of mitochondrial dysfunction and monoamine oxidase contribution to oxidative stress in human diabetic hearts","volume":"2016","author":"Duicu","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejphar.2021.174081_bib13","first-page":"5","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.ejphar.2021.174081_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.yjmcc.2006.12.018","article-title":"Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy","volume":"42","author":"Hamblin","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","article-title":"Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus","volume":"47","author":"Herrero","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib16","doi-asserted-by":"crossref","first-page":"E1687","DOI":"10.1152\/ajpendo.00256.2007","article-title":"Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling","volume":"293","author":"Hong","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2021.174081_bib17","doi-asserted-by":"crossref","first-page":"20467","DOI":"10.1038\/srep20467","article-title":"Nanoparticle-mediated targeting of cyclosporine A enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening","volume":"6","author":"Ikeda","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174081_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004385","article-title":"Loss of UCP2 attenuates mitochondrial dysfunction without altering ROS production and uncoupling activity","volume":"10","author":"Kukat","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ejphar.2021.174081_bib19","first-page":"656","article-title":"[A new insulin-sensitivity index for the population-based study]","volume":"32","author":"Li","year":"1993","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.ejphar.2021.174081_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.174081_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2017.01.041","article-title":"Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits","volume":"798","author":"Lin","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174081_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study","volume":"378","author":"Lind","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.174081_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2009.08.035","article-title":"Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells","volume":"209","author":"Lu","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2021.174081_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/ars.2018.7707","article-title":"Energetic dysfunction is mediated by mitochondrial reactive oxygen species and precedes structural remodeling in metabolic heart disease","volume":"31","author":"Luptak","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2021.174081_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2021.174081_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-015-0309-x","article-title":"The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus","volume":"14","author":"Matyas","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2021.174081_bib27","doi-asserted-by":"crossref","first-page":"H2046","DOI":"10.1152\/ajpheart.2001.280.5.H2046","article-title":"Impaired sarcoplasmic reticulum function leads to contractile dysfunction and cardiac hypertrophy","volume":"280","author":"Meyer","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"99","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.174081_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","article-title":"Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients","volume":"130","author":"Montaigne","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2021.174081_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/jehp.jehp_194_17","article-title":"The impact of poor glycemic control on lipid profile variables in children with type 1 diabetes mellitus","volume":"8","author":"Mostofizadeh","year":"2019","journal-title":"J. Educ. Health Promot."},{"key":"10.1016\/j.ejphar.2021.174081_bib31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2021.174081_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3109\/10715762.2011.605361","article-title":"Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia\/reperfusion injury in diabetic rat heart","volume":"45","author":"Okazaki","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2021.174081_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mcn.2013.10.002","article-title":"UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis","volume":"57","author":"Peixoto","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174081_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2337\/db07-1189","article-title":"Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension","volume":"57","author":"Perticone","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174081_bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2005.04.040","article-title":"Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension","volume":"46","author":"Perticone","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2018.03.037","article-title":"Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients","volume":"261","author":"Potocnjak","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2009.08.106","article-title":"Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways","volume":"389","author":"Ragheb","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174081_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF02005186","article-title":"Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate","volume":"81","author":"R\u00f6sen","year":"1986","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib40","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejphar.2021.174081_bib41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diabetes.55.03.06.db05-1039","article-title":"Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy","volume":"55","author":"Shen","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2021.174081_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2015.12.001","article-title":"Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging","volume":"90","author":"Shepherd","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2021.174081_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardiores.2007.04.030","article-title":"Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury","volume":"75","author":"Stuhlinger","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2021.174081_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-016-0460-z","article-title":"N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3\/eNOS signaling in diabetic rats","volume":"15","author":"Su","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2021.174081_bib45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1475-2840-12-64","article-title":"Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study","volume":"12","author":"Surdacki","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2021.174081_bib46","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbadis.2016.08.021","article-title":"Mitochondrial dysfunction and its impact on diabetic heart","volume":"1863","author":"Verma","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2021.174081_bib47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCRESAHA.107.158915","article-title":"Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor\/NO","volume":"101","author":"Wang","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2021.174081_bib48","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1159\/000374021","article-title":"Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1alpha and akt activation","volume":"35","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2021.174081_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174081_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12986-020-00486-4","article-title":"Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats","volume":"17","author":"Xiong","year":"2020","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejphar.2021.174081_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.lfs.2004.10.062","article-title":"Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes","volume":"77","author":"Xiong","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2021.174081_bib52","first-page":"149","article-title":"Endogenous inhibitors of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits","volume":"17","author":"Xiong","year":"1996","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.ejphar.2021.174081_bib53","first-page":"511","article-title":"Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum","volume":"18","author":"Xiong","year":"1997","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.ejphar.2021.174081_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12241","article-title":"Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway","volume":"35","author":"Zhou","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ejphar.2021.174081_bib55","first-page":"749","article-title":"DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH\/ADMA\/NOS\/NO pathway in rats","volume":"43","author":"Zhu","year":"2019","journal-title":"Int. J. Mol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:12:15Z","timestamp":1762143135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100234X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":55,"alternative-id":["S001429992100234X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174081","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174081"}}